PA
RETA

Parallel Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Parallel Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$2.55K Hold
2023
Q1 		$2.27K Buy
2022
Q1 		– Sell
2021
Q4 		$0 Sell
2021
Q3 		$9K Buy
2021
Q2 		$6K Sell
2021
Q1 		$7K Buy
2020
Q4 		$1K Hold
2020
Q3 		$1K Sell
2020
Q2 		$2K Buy